Abstract
A heavy-ion synchrotron facility, HIMAC (Heavy Ion Medical Accelerator in Chiba), began operating in 1993 at the National Institute of Radiological Sciences, Japan. The primary purpose of HIMAC is to carry out a clinical studies of ‘cancer treatment using heavy ion beams’. Treatment employing carbon beams began in June, 1994, and about 150 patients had been treated by the end of July, 1996. The accelerator of HIMAC, which comprises linear accelerators as an injector and a synchrotron, can accelerate ion beams ranging from helium to argon with a maximum energy of 800 MeV/nucleon for ions with a charge-to-mass ratio of 1/2. The research activities at HIMAC are not limited to medical applications, but include a wide area of research: physics, chemistry, biology, engineering, etc.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
